NO992316L - Benzensulfonamidderivater og legemidler inneholdende disse - Google Patents

Benzensulfonamidderivater og legemidler inneholdende disse

Info

Publication number
NO992316L
NO992316L NO992316A NO992316A NO992316L NO 992316 L NO992316 L NO 992316L NO 992316 A NO992316 A NO 992316A NO 992316 A NO992316 A NO 992316A NO 992316 L NO992316 L NO 992316L
Authority
NO
Norway
Prior art keywords
benzenesulfonamide derivatives
drugs containing
derivatives
hydrogen
lower alkyl
Prior art date
Application number
NO992316A
Other languages
English (en)
Other versions
NO992316D0 (no
Inventor
Shingo Yasuda
Nobuo Ogawa
Shunichiro Sakurai
Original Assignee
Hokuriku Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical filed Critical Hokuriku Pharmaceutical
Publication of NO992316D0 publication Critical patent/NO992316D0/no
Publication of NO992316L publication Critical patent/NO992316L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

Nye benzensulfonamidderivater av generell formel (I) ----v .X" -^ V- (hvori R1 er hydrogen, halogen, lavere alkyl, lavere alkoksy eller nitro; R2 er C4-Ca-alkyl substituert med en eller flere fluor- atomer; R3 er hydrogen eller lavere alkyl; X er svovel eller CH=CH; og n er et helt tall fra 2 til 4). Legemidler inneholdende deri- vatene som aktiv bestanddel, er anvend bare for forhindring og/eller behand- ling av trombose, astma eller aller- giske sykdommer.
NO992316A 1996-11-13 1999-05-12 Benzensulfonamidderivater og legemidler inneholdende disse NO992316L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP31710996 1996-11-13
JP9269234A JPH10195038A (ja) 1996-11-13 1997-09-16 ベンゼンスルホンアミド誘導体及びそれを含有する医薬
PCT/JP1997/004125 WO1998021177A1 (fr) 1996-11-13 1997-11-12 Derives benzenesulfonamide et medicaments les contenant

Publications (2)

Publication Number Publication Date
NO992316D0 NO992316D0 (no) 1999-05-12
NO992316L true NO992316L (no) 1999-07-12

Family

ID=26548679

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992316A NO992316L (no) 1996-11-13 1999-05-12 Benzensulfonamidderivater og legemidler inneholdende disse

Country Status (17)

Country Link
EP (1) EP0943606A1 (no)
JP (1) JPH10195038A (no)
KR (1) KR20000053254A (no)
CN (1) CN1244859A (no)
AU (1) AU716395B2 (no)
BG (1) BG103395A (no)
BR (1) BR9712763A (no)
CA (1) CA2271673A1 (no)
CZ (1) CZ169399A3 (no)
EA (1) EA199900460A1 (no)
ID (1) ID21835A (no)
IL (1) IL129574A0 (no)
NO (1) NO992316L (no)
PL (1) PL333287A1 (no)
SK (1) SK61199A3 (no)
TR (1) TR199900984T2 (no)
WO (1) WO1998021177A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007526249A (ja) * 2004-01-30 2007-09-13 グレート・レークス・ケミカル・コーポレーション 生産プロセスおよびシステム、組成物、界面活性剤、モノマー単位、金属錯体、リン酸エステル、グリコール、水性膜形成発泡体、および発泡安定化剤
CN1922122A (zh) * 2004-01-30 2007-02-28 大湖化学公司 组合物、卤代组合物、化学生产和调聚反应方法
JP2007528917A (ja) * 2004-01-30 2007-10-18 グレート・レークス・ケミカル・コーポレーション 製造方法並びにシステム、組成物、界面活性剤、モノマー単位、金属錯体、燐酸エステル、グリコール、水性皮膜形成フォーム、及びフォーム安定剤
CA2554293A1 (en) * 2004-01-30 2005-08-18 Great Lakes Chemical Corporation Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams, and foam stabilizers
JP5087404B2 (ja) * 2005-09-27 2012-12-05 株式会社カネカ 光学活性ベンジルアミン誘導体の製造方法
JP2011088825A (ja) * 2008-01-16 2011-05-06 Kaken Pharmaceutical Co Ltd 鼻閉症治療用経粘膜投与製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753505A (ja) * 1992-10-01 1995-02-28 Hokuriku Seiyaku Co Ltd ベンゼンスルホンアミド誘導体及びその用途
JPH0948775A (ja) * 1995-06-02 1997-02-18 Hokuriku Seiyaku Co Ltd （２−チエニル）アルカン酸誘導体

Also Published As

Publication number Publication date
ID21835A (id) 1999-08-05
WO1998021177A1 (fr) 1998-05-22
IL129574A0 (en) 2000-02-29
EA199900460A1 (ru) 2000-02-28
TR199900984T2 (xx) 1999-07-21
NO992316D0 (no) 1999-05-12
SK61199A3 (en) 1999-11-08
CA2271673A1 (en) 1998-05-22
BR9712763A (pt) 1999-12-21
PL333287A1 (en) 1999-11-22
CN1244859A (zh) 2000-02-16
AU716395B2 (en) 2000-02-24
BG103395A (en) 2000-02-29
KR20000053254A (ko) 2000-08-25
AU4964597A (en) 1998-06-03
CZ169399A3 (cs) 1999-11-17
EP0943606A1 (en) 1999-09-22
JPH10195038A (ja) 1998-07-28

Similar Documents

Publication Publication Date Title
MY107740A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
BR0015193A (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratamento de uma condição associada com trasmissão reduzida de nicotina, para tratamento ou profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e para tratamento ou profilaxia de doenças ou condições humanas
BR0212864A (pt) Derivados de 1,6-naftiridina como antidiabéticos
NO20050016L (no) Difenylazetidinonderivater for behandling av forstyrrelser i lipid metabolismen
DK0896533T3 (da) Pentafluorbenzensulfonamider og analoger
DK0687268T3 (da) Spiroazacykliske derivater som substans P-antagonister
DK1105393T3 (da) Bicykliske piperidin- og piperazinforbindelser med 5-HT6-receptoraffinitet
DK0613894T3 (da) N-Heteroaryl-N'-phenylurinstofderivater, fremstilling og anvendelse deraf
HUP0002272A2 (hu) Piperazinszármazékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
FR2712591B1 (fr) Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
CA2238875A1 (en) Tri-aryl ethane derivatives as pde iv inhibitors
DE69215694D1 (de) Benzamid-derivate
TR200103349T2 (tr) Purin türevleri, hazırlama usulü ve bunları içeren ispençiyari bileşimleri.
HUP0001164A2 (hu) PF1022-ciklodepszipeptid-származékok
NO971625L (no) Nye peptider med immunomodulatoriske effekter
EA200100090A2 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
NO882334D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO994659L (no) Nye pyridinderivater og farmasöytiske preparater inneholdende slike
NO992316L (no) Benzensulfonamidderivater og legemidler inneholdende disse
NO20055749L (no) Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
DK0452204T3 (da) Hidtil ukendte 3-aminochromanderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application